Clinical Trials Sponsored by ICON Bioscience Inc

Total 777 results

Ventrus Biosciences, Inc

Unknown

An Open-Label, Single- and Multi-Dose Pharmacokinetic (PK) Study of Oral Diltiazem and Topical Diltiazem Hydrochloride

Adult Subjects With Anal Fissures.

United States
Regado Biosciences, Inc.

Completed

Safety, Tolerability and PK/PD of RB006 in a Healthy Volunteer SAD (SC101)

Healthy Volunteer

United States
Lux Biosciences, Inc.

Completed

Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis

Noninfectious Uveitis

France, United States, Italy, Germany, Canada, United Kingdom, Czech Republic, Austria, Brazil
Cortice Biosciences, Inc.

Completed

Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies

Neoplasms | Non-Hodgkin's Lymphoma | Hodgkin's Disease

United States
Alacrity Biosciences, Inc.

Completed

A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period

Dry Eye

United States
Spartan Bioscience Inc.
Beaufort

Completed

Clinical Study Spartan COVID-19 V2 System

Covid19

United States
Amarantus BioScience Holdings, Inc.

Unknown

A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients

Parkinson's Disease | Dyskinesia

United States
Xencor, Inc.
ICON Early Phase Services, LLC

Completed

Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195

Healthy Volunteers | Atopic Disease

United States
Iron Horse Diagnostics, Inc.

Unknown

A Study to Evaluate the Performance of a Diagnostic Test in ALS

Amyotrophic Lateral Sclerosis (ALS)

United States
Phylos Bioscience, Inc.
People Science, Inc.

Recruiting

A Direct-to-Consumer Study Investigating the Effect of Specific Cannabinoid Products on Motivation, Energy Level, Focus, and Appetite in Healthy Adults

Motivation

United States
Mirati Therapeutics Inc.
Aadi Bioscience, Inc.

Active, not recruiting

Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19)

NSCLC | Metastatic Cancer | Advanced Cancer | Solid Tumor, Adult | Malignant Neoplastic Disease

United States
Vifor Pharma
ICON Clinical Research; American Regent, Inc.

Completed

Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (FIND-CKD)

Chronic Kidney Disease | Iron Deficiency Anaemia

United Kingdom, United States, Australia, Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, Turkey
CAGE Bio Inc.
BioScience Laboratories, Inc.

Completed

Clinical Evaluation of the Residual Antimicrobial Activity

Bacterial Overgrowth

United States
Cogent Biosciences, Inc.
Seagen Inc.

Terminated

Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in Relapse

United States
Deacon Biosciences, Inc.
ORA, Inc.

Completed

A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers

Ocular Infection

United States
Enanta Pharmaceuticals, Inc
ICON Clinical Research; Triangle Biostatistics

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis

Non-Alcoholic Steatohepatitis

United States, United Kingdom, New Zealand, Canada, France, Puerto Rico
Shanghai Junshi Bioscience Co., Ltd.
CTI Clinical Trial and Consulting Services; TopAlliance Biosciences, Inc.

Withdrawn

A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies

Malignancies | Previously Treated, Advanced
Meridian Bioscience, Inc.
Conatus Pharmaceuticals

Completed

Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14

Cirrhosis | Portal Hypertension | NASH - Nonalcoholic Steatohepatitis

France
Forest Laboratories
Cypress Bioscience, Inc.

Terminated

Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia (MyFi)

Primary Fibromyalgia

United States
Forest Laboratories
Cypress Bioscience, Inc.

Completed

Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia

Fibromyalgia

United States
Exelixis
Arcus Biosciences, Inc.

Recruiting

Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009)

Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors

United States
Emalex Biosciences Inc.
Covance

Completed

Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects

Healthy Volunteer

United Kingdom
Coherus Biosciences, Inc.
Shire

Completed

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)

Plaque Psoriasis

United States, Israel, Australia, Germany, South Africa, Poland, Canada
MBX Biosciences
ProSciento, Inc.

Recruiting

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects

Postbariatric Hypoglycemia

United States
Alume Biosciences, Inc.
Ergomed

Recruiting

ALM-488 for Intra-Operative Visualization of Nerves in Head and Neck Surgery

Surgery

United States
AstraZeneca
Arcus Biosciences, Inc.

Recruiting

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC (PACIFIC-8)

Non-Small Cell Lung Cancer

Korea, Republic of, Philippines, United States, Belgium, Hungary, India, Norway, United Kingdom, France, Canada, Germany, Japan, Malaysia, Taiwan, Greece, Italy, Mexico, Turkey, South Africa, Chile, Brazil, Spain, Switzerland, Poland, R... and more
Leonard-Meron Biosciences, Inc.

Available

Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI (MLK)

Catheter-Related Infections

United States, Puerto Rico
AstraZeneca
Ardea Biosciences, Inc.

Completed

Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia

Gout and Hyperuricemia

Japan
CeloNova BioSciences, Inc.
AlpinARC

Completed

Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry (eCOBRA)

Myocardial Infarction | Stable Angina | Unstable Angina | STEMI | NSTEMI - Non-ST Segment Elevation MI | ACS - Acute Coronary Syndrome

France
AstraZeneca
Ardea Biosciences, Inc.

Completed

A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients

Gout and Asymptomatic Hyperuricemia

Japan
BioNumerik Pharmaceuticals, Inc.
Crown Bioscience

Completed

Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer

Ovarian Cancer

Poland, Russian Federation, Romania, Hungary, Lithuania
BioNumerik Pharmaceuticals, Inc.
Crown Bioscience

Completed

Study of Karenitecin (BNP1350) to Treat Malignant Melanoma

Melanoma | Neoplasm

United States
Perle Bioscience, Inc.
Syreon Corporation

Withdrawn

The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients (IIT)

Type 1 Diabetes
Altor BioScience
Genentech, Inc.; Tanox

Completed

Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome

Sepsis | Acute Respiratory Distress Syndrome | Acute Lung Injury

United States, Canada
Forest Laboratories
Cypress Bioscience, Inc.

Completed

Study of Milnacipran for the Treatment of Fibromyalgia

Fibromyalgia

United States
Forest Laboratories
Cypress Bioscience, Inc.

Completed

A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring

Fibromyalgia

United States
Alume Biosciences, Inc.
Ergomed

Recruiting

Feasibility Study- REVEAL 475 for Bevonescein-Assisted Nerve Visualization in Head & Neck Surgery

Head and Neck Surgery

United States
Exeliom Biosciences
Alimentiv Inc.

Recruiting

EXL01 in the Maintenance of Steroid-induced Clinical Response/Remission in Participants With Mild to Moderate Crohn's Disease (MAINTAIN)

Crohn Disease

Poland, Belgium
Leonard-Meron Biosciences, Inc.

Recruiting

Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

Catheter-related Infections

United States, Puerto Rico
KBP Biosciences
Medpace, Inc.

Completed

Bioavailability of KBP-5074 Tablet vs Capsule Formulations

Bioequivalence

United States
Cogent Biosciences, Inc.
Plexxikon

Completed

CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors

Gastrointestinal Stromal Tumors

United States
Meridian Bioscience, Inc.
Conatus Pharmaceuticals

Terminated

Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17

Decompensated Cirrhosis

United States
INVO Bioscience, Inc.
Ferring Pharmaceuticals

Suspended

Assessment of the INVOcell Intravaginal Culture System

Infertility

United States
BioNumerik Pharmaceuticals, Inc.
Crown Bioscience

Completed

Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer

Carcinoma | Carcinoma, Non-Small-Cell Lung

United States
BioNumerik Pharmaceuticals, Inc.
Crown Bioscience

Completed

Study of Karenitecin (BNP1350) in Patients With Brain Tumors

Brain Neoplasms | Brain Tumors | Malignant Neoplasms, Brain

United States
Forest Laboratories
Cypress Bioscience, Inc.

Terminated

Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia (MyFi)

Primary Fibromyalgia

United States
Forest Laboratories
Cypress Bioscience, Inc.

Completed

Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia

Fibromyalgia

United States
4D pharma plc
ICON plc; Labcorp Drug Development Inc

Withdrawn

Study to Assess the Safety of MRx0029 or MRx0005 Compared to Placebo, in People With Parkinson's

Idiopathic Parkinson Disease
Lundbeck LLC
Quintiles, Inc.; ICON Clinical Research; Ligand Pharmaceuticals

Completed

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Epilepsy

United States
Arcus Biosciences, Inc.
Infinity Pharmaceuticals, Inc.

Completed

A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies

Ovarian Cancer | TNBC - Triple-Negative Breast Cancer

United States, Australia

Clinical Trials Sponsored by ICON Bioscience Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations